Academic yr: <<< Previous
2011
2012
2013
|
2014
|
2015
Next >>>
Department of Internal Medicine, Division of Hematology
|
■ Summary
|
■ Research grants & projects
1.
|
(Grant No.:25461443)
Budget amount:\1,950,000 (Principal investigator)
|
2.
|
(Grant No.:H23-がん臨床-一般-022)
Budget amount:\1,000,000 (Co-investigator)
|
3.
|
(Grant No.:H23-免疫-一般-009)
Budget amount:\500,000 (Co-investigator)
|
4.
|
(Grant No.:H23-免疫-一般-014)
Budget amount:\300,000 (Co-investigator)
|
5.
|
(Grant No.:H23-免疫-一般-010)
Budget amount:\900,000 (Co-investigator)
|
6.
|
(Grant No.:H23-がん臨床-一般-020)
Budget amount:\150,000 (Research collaborator)
|
7.
|
(Grant No.:23591409)
Budget amount:\1,040,000 (Principal investigator)
|
8.
|
Budget amount:\1,500,000 (Principal investigator)
|
9.
|
Budget amount:\500,000 (Principal investigator)
|
Display 5 items
|
Display all(9)
|
To the top
|
|
■ Research works
Journal |
Book |
Presentation |
Other presentations |
Japanese | English |
Japanese | English |
Domestic | international |
First author | Corresponding Author | Co-author | First author | Corresponding Author | Co-author |
First author | Co-author | First author | Co-author |
Presenter | Co-presenter | Presenter | Co-presenter |
Presenter | Co-presenter |
4 | 0 | 2 | 4 | 4 | 11 |
0 | 7 | 0 | 0 |
15 | 1 |
4 | 5 |
0 | 0 |
|
To the top
|
|
■ Published papers
Original article
|
1.
|
KOBAYASHI R†, TANAKA Junji, HASHINO S, OTA S, TORIMOTO Y, KAKINOKI Y, YAMAMOTO S, KUROSAWA M, HATAKEYAMA N, HASEYAMA Y, SAKAI H, SATO K, FUKUHARA T:
Etoposide-containing conditioning regimen reduces the occurrence of hemophagocytic lymphohistiocytosis after SCT.
Bone marrow transplantation
49
(2)
:254-257
, 2014.2
DOI:10.1038/bmt.2013.145
|
2.
|
Shinohara Akihito, Imai Yoichi, Nakagawa Masahiro, Takahashi Tsuyoshi, Ichikawa Motoshi, Kurokawa Mineo:
Intracellular reactive oxygen species mark and influence the megakaryocyte-erythrocyte progenitor fate of common myeloid progenitors.
Stem cells (Dayton, Ohio)
32
(2)
:548-57
, 2014.2
DOI:10.1002/stem.1588
|
3.
|
SHIOZAKI Hiroko†, YOSHINAGA Kentaro*, KONDO Toshiaki, IMAI Yoichi, SHISEKI Masayuki, MORI Naoki, TERAMURA Masanao, MOTOJI Toshiko*:
Donor cell-derived leukemia after cord blood transplantation and a review of the literature: differences between cord blood and BM as the transplant source.
Bone marrow transplantation
49
(1)
:102-109
, 2014.1
|
4.
|
HAYASE E†, FUJIMOTO K, MITSUHASHI T, HATANAKA Y, YOSHIDA M, TAKEMURA R, IWASAKI J, SHIRATORI S, SUGITA J, KONDO T, TANAKA J, IMAMURA M, MATSUNO Y, TESHIMA T:
Epstein-barr virus-associated smooth muscle tumors after bone marrow transplantation.
Transplantation
97
(1)
:e1-5
, 2014.1
DOI:10.1097/01.TP.0000437912.60638.23.
|
5.
|
TANAKA Junji†*, MORISHIMA Y, TAKAHASHI Y, YABE T, OBA K, TAKAHASHI S, TANIGUCHI S, OGAWA H, ONISHI Y, MIYAMURA K, KANAMORI H, AOTSUKA N, KATO K, KATO S, ATSUTA Y, KANDA Y:
Effects of KIR ligand incompatibility on clinical outcomes of umbilical cord blood transplantation without ATG for acute leukemia in complete remission.
Blood Cancer Journal
3
(11)
:e164
, 2013.11
|
6.
|
NISHIWAKI S†, ATSUTA Y, TANAKA Junji:
Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative ALL: what should we choose when no HLA-matched related donor is available?.
Bone marrow transplantation
48
(11)
:1369-1376
, 2013.11
|
7.
|
TANAKA Junji†*, KANAMORI H, NISHIWAKI S, OHASHI K, TANIGUCHI S, ETO T, NAKAMAE H, MINAGAWA K, MIYAMURA K, SAKAMAKI H, MORISHIMA Y, KATO K, SUZUKI R, NISHIMOTO N, OBA K, MASAUZI N:
Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: a study from the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT).
Bone marrow transplantation
48
(11)
:1389-1394
, 2013.11
|
8.
|
KANAMORI H†, MIZUTA S, KAKO S, KATO H, NISHIWAKI S, IMAI K, SHIGEMATSU A, NAKAMAE H, TANAKA M, IKEGAME K, YUJIRI T, FUKUDA T, MINAGAWA K, ETO T, NAGAMURA-INOUE T, MORISHIMA Y, SUZUKI R, SAKAMAKI H, TANAKA Junji:
Reduced-intensity allogeneic stem cell transplantation for patients aged 50 years or older with B-cell ALL in remission: a retrospective study by the Adult ALL Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Bone marrow transplantation
48
(12)
:1513-1518
, 2013.11
|
9.
|
MORI Naoki†*, OHWASHI Mari, YOSHINAGA Kentaro, MITSUHASHI Kenjiro, TANAKA Norina, TERAMURA Masanao, OKADA Michiko, SHISEKI Masayuki, TANAKA Junji, MOTOJI Toshiko:
L265P mutation of the MYD88 gene is frequent in Waldenström's macroglobulinemia and its absence in myeloma.
PLoS ONE
8
(11)
:e80088
, 2013.11
DOI:10.1371/journal.pone.0080088.
|
10.
|
KUROSAWA S†, YAKUSHIJIN K, YAMAGUCHI T, ATSUTA Y, NAGAMURA-INOUE T, AKIYAMA H, TANIGUCHI S, MIYAMURA K, TAKAHASHI S, ETO T, OGAWA H, KUROKAWA M, TANAKA Junji, KAWA K, KATO K, SUZUKI R, MORISHIMA Y, SAKAMAKI H, FUKUDA T:
Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia.
Bone marrow transplantation
48
(9)
:1198-1204
, 2013.9
|
11.
|
TORIMOTO Y†, SATO K, IKUTA K, HAYASHI T, HIRAYAMA Y, INAMURA J, KOBAYASHI H, KOBAYASHI R, KODA K, KUROSAWA M, MORI A, OTA S, SAKAI H, SHIGEMATSU A, SHINDO M, SHINZAKI H, TAKAHASHI F, TAKIMOTO R, TANAKA Junji, YAMAMOTO S, KOHGO Y, FUKUHARA T:
A retrospective clinical analysis of Japanese patients with peripheral T-cell lymphoma not otherwise specified: Hokkaido Hematology Study Group.
International Journal of Hematology
98
(2)
:171-178
, 2013.8
|
12.
|
NISHIWAKI S†, MIYAMURA K, OHASHI K, KUROKAWA M, TANIGUCHI S, FUKUDA T, IKEGAME K, TAKAHASHI S, MORI T, IMAI K, IIDA H, HIDAKA M, SAKAMAKI H, MORISHIMA Y, KATO K, SUZUKI R, TANAKA Junji:
Impact of a donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO
24
(6)
:1594-1602
, 2013.6
|
13.
|
WAKAO H†, YOSHIKIYO K, KOSHIMIZU U, FURUKAWA T, ENOMOTO K, MATSUNAGA T, TANAKA T, YASUTOMI Y, YAMADA T, MINAKAMI H, TANAKA Junji, ODA A, SASAKI T, WAKAO R, LANTS O, UDAGAWA T, SEKIYA Y, HIGUCHI K, HARADA N, NISHIMURA K, OHTAKA M, NAKANISHI M, FUJITA H:
Expansion of functional human mucosal-associated invariant T cells via reprogramming to pluripotency and redifferentiation.
Cell Stem Cell
12
(5)
:546-558
, 2013.5
|
14.
|
KUROSAWA S†, YAKUSHIJIN K, YAMAGUCHI T, ATSUTA Y, NAGAMURA-INOUE T, AKIYAMA H, TANIGUCHI S, MIYAMURA K, TAKAHASHI S, ETO T, OGAWA H, KUROKAWA M, MORISHIMA Y, TANAKA Junji, SAKAMAKI H, FUKUDA T:
Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry.
Bone marrow transplantation
48
(4)
:529-536
, 2013.4
|
15.
|
Shinohara Akihito, Yoshiki Yumiko, Masamoto Yosuke, Hangaishi Akira, Nannya Yasuhito, Kurokawa Mineo:
Moxifloxacin is more effective than tosufloxacin in reducing chemotherapy-induced febrile neutropenia in patients with hematological malignancies.
Leukemia & lymphoma
54
(4)
:794-798
, 2013.4
DOI:10.3109/10428194.2012.725848
|
Display 5 items
|
Display all(15)
|
Review article
|
1.
|
田中淳司†:
多発性骨髄腫.
耳鼻咽喉科・頭頸部外科
86
(3)
:258-262
, 2014.3
|
2.
|
今井陽一†:
がんの最新治療 各論(5)多発性骨髄腫.
東京女子医科大学雑誌
83
(3)
:160-167
, 2013.6
|
3.
|
田中淳司†:
造血細胞移植におけるNK細胞の役割.
日本造血細胞移植学会雑誌
2
(4)
:85-93
, 2013.4
|
Case report
|
1.
|
早瀬英子†, 杉田純一, 藤本勝也, 江端浩, 山川知宏, 吉田美穂, 竹村龍, 岩崎純子, 高橋正二郎, 白鳥聡一, 近藤健, 田中淳司, 豊嶋崇徳:
ビンクリスチンによる麻痺性イレウスに引き続きposterior reversible encephalopathy syndromeを発症したT細胞性リンパ芽球性リンパ腫.
臨床血液
55
(2)
:249-253
, 2014.2
|
2.
|
志村華絵†, 今井陽一, 田中淳司*:
私のこの一枚(115) 腹腔内巨大腫瘍で発症した腎移植後リンパ増殖性疾患.
血液フロンティア
24
(1)
:5-10
, 2014.1
|
3.
|
後藤亜江子†, 鶴岡直樹, 三浦ひとみ, 浅畑さやか, 相野田祐介, 藤田崇宏, 平井由児, 戸塚恭一*:
都市部汚水曝露が原因となったAeromonas hydrophilaによる皮膚軟部組織感染症の1例.
日本臨床微生物学雑誌
23
(2)
:102-6
, 2013.6
|
To the top
|
|
■ Books
1.
|
相野田祐介:
標準予防策.
臨床感染症ブックレット8
2-7.
文光堂,
東京、日本,
2013.9
|
2.
|
相野田祐介:
オキサゾリジノン系抗菌薬.
抗菌薬の選び方・使い方ハンドブック
150-2.
羊土社,
東京、日本,
2013.9
|
3.
|
田中淳司:
NK細胞と移植免疫.
GVHD(移植片対宿主病)の基礎と臨床
73-85.
医薬ジャーナル社,
大阪,
2013.8
|
4.
|
相野田祐介, 浅畑さやか, 平井由児, 藤田崇宏, 戸塚恭一:
日本語版サンフォード感染症治療ガイド2013
1-.
ライフ・サイエンス出版,
東京、日本,
2013.7
|
5.
|
今井陽一:
再発の定義と再発例の治療目標.
多発性骨髄腫Updating 第3巻 多発性骨髄腫の治療目標~初期治療のエンドポイントから再発例の治療目標まで~
112-119.
医薬ジャーナル社,
大阪,
2013.7
|
6.
|
田中淳司:
Lymphoid myelofibrosis.
別冊 日本臨牀 血液症候群Ⅲ
108-109.
日本臨牀社,
大阪,
2013.5
|
7.
|
田中淳司:
Neutrophilic myelofibrosis.
別冊 日本臨牀 血液症候群Ⅲ
110-111.
日本臨牀社,
大阪,
2013.5
|
Display 5 items
|
Display all(7)
|
To the top
|
|
■ Academic conference presentation
1.
|
◎SHISEKI Masayuki, ISHII Mayuko, MITSUHASHI Kenjiro, TANAKA Norina, YOSHINAGA Kentaro, MORI Naoki, TANAKA Junji:
Prognostic Implications Of PRAME Expression Levels In Myelodysplastic Syndromes.
55th ASH Annual Meeting and Exposition,
New Orleans, USA,
2013/12
|
2.
|
◎SANO H, KOBAYASHI R, TANAKA Junji, HASHINO S, OTA S, TORIMOTO Y, KAKINOKI Y, YAMAMOTO S, KUROSAWA M, HATAKEYAMA N, HASEYAMA Y, SAKAI H, SATO K, FUKUHARA T:
Risk Factor Analysis Of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndromes: A Multicenter Study.
55th ASH Annual Meeting and Exposition,
New Orleans, USA,
2013/12
|
3.
|
◎YAMASHITA T, KUWABARA H, OHASHI K, UCHIDA N, FUKUDA T, MIYAMURA K, MORI S, KATO K, TANAKA Junji, ADACHI S, ATSUTA Y:
Late Relapse After Allogeneic Hematopoietic Cell Transplantation For Hematological Malignancies: A Nationwide Retrospective Study From The Late Complications and Quality-Of-Life Working Group Of The Japan Society For Hematopoietic Cell Transplantation.
55th ASH Annual Meeting and Exposition,
New Orleans, USA,
2013/12
|
4.
|
◎YANO S, YOKOYAMA H, UCHIDA N, KAKIHANA K, FUKUDA T, KANAMORI H, OGAWA H, NAGAMURA T, TANAKA J, MORISHIMA Y, ATSUTA Y, TAMAKI A:
Influence Of Donor Source On Relapse and Survival In Patients With Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Analysis From The Japan Society For Hematopoietic Cell Transplantation (JSHCT) AML Working Group.
55th ASH Annual Meeting and Exposition,
New Orleans, USA,
2013/12
|
5.
|
◎MORI Naoki, OHWASHI Mari, YOSHINAGA Kentaro, MITSUHASHI Kenjiro, TANAKA Norina, OKADA Michiko, SHISEKI Masayuki, MOTOJI Toshiko:
Frequent mutation of the MYD88 gene in macroglobulinemia.
18th Congress of the European Hematology Association,
Stockholm, Sweden,
2013/06
|
6.
|
◎SHIRATORI S, AKIZAWA K, SUGITA J, SHIGEMATSU A, FUJIMOTO K, ENDO T, KONDO T, HASHINO S, TANAKA Junji, TESHIMA T:
Stenotrophomonas maltophilia infection in allogeneic hematopoietic stem cell transplantation-risk factors and therapeutic-strategies.
18th Congress of the European hematology Association,
Stockholm, Sweden,
2013/06
|
7.
|
◎TANAKA Junji, TAKAHASHI Y, YABE T, MORISHIMA Y, OBA K, TAKAHASHI S, TANIGUCHI S, OGAWA H, OHNISHI Y, MIYAMURA K, KATO K, KATO S, ATSUTA Y, KANDA Y:
KIR-ligand incompatibility in the graft-versus-host direction did not affect outcomes of single umbilical cord blood transplantation without ATG for acute leukemia in complete remission.
18th Congress of the European hematology Association,
Stockholm, Sweden,
2013/06
|
8.
|
◎Yusuke Ainoda, Sayaka Asahata, Takahiro Fujita, Yuji Hirai, Kyoichi Totsuka:
Evaluation of Susceptibility to Oxacillin and Prognosis in Patients with S. lugdunensis Bacteremia.
28th International Congress of Chemotherapy and Infection,
Yokohama, Japan,
2013/06
|
9.
|
◎IMAI Yoichi, OHTA Eri, WANG Yanhua, KITAGAWA Yukiko, DING Ye, YAMADA Osamu, MARU Yoshiro, MOTOJI Toshiko:
Identification of calcineurin as a novel therapeutic target in multiple myeloma.
14th International Myeloma Workshop,
Kyoto, Japan,
2013/04
|
10.
|
◎テインイエ, 三橋健次郎, 阿部香代子, 吉永健太郎, 今井陽一, 志関雅幸, 森直樹, 田中淳司:
ネララビン療法および臍帯血移植後に脊髄異常画像所見と神経障害を認めたT-LBLの一例.
第36回日本造血細胞移植学会総会,
宜野湾,
2014/03
|
11.
|
◎王艶華, 今井陽一, 志関雅幸, テインイエ, 泉二登志子:
Knock-down of FZD1 reduced MDR1/P-gp expression in leukemic cells through the Wnt/β-catenin pathway.
第75回日本血液学会学術集会,
札幌,
2013/10
|
12.
|
◎今井陽一, 太田瑛里, 王艶華, テインイエ, 丸義朗, 泉二登志子:
Identification of PPP3CA, catalytic subunit of Calcineurin as a target of multiple myeloma therapy.
第75回日本血液学会学術集会,
札幌,
2013/10
|
13.
|
◎三橋健次郎, 増田昭博, 王艶華, 志関雅幸, 田中淳司, 泉二登志子:
Prognostic significance of PRAME expression based on IHC for DLBCL patients treated with R-CHOP.
第75回日本血液学会学術集会,
札幌,
2013/10
|
14.
|
◎志村華絵, 兒玉聖子, 吉永健太郎, 松本雅則, 藤村 吉博, 榎本有希, 今井陽一, 志関雅幸, 森直樹, 寺村正尚, 泉二登志子:
Thrombotic thrombocytopenic purpura diagnosed after a twenty-year history of thrombocytopenia.
第75回日本血液学会学術集会,
札幌,
2013/10
|
15.
|
◎森直樹, 王鷲真理, 吉永健太郎, 三橋健次郎, 田中紀奈, 岡田美智子, 志関雅幸, 田中淳司, 泉二登志子:
Analysis of L265P mutation in the MYD88 gene in Waldenstrom's macroglobulinemia.
第75回日本血液学会学術集会,
札幌,
2013/10
|
16.
|
◎石山みどり, 吉永健太郎, 三橋健次郎, 風間啓至, 今井陽一, 志関雅幸, 森直樹, 寺村正尚, 瀬下明良, 泉二登志子:
Long term efficacy of laparoscopic splenectomy for immune thrombocytopenia.
第75回日本血液学会学術集会,
札幌,
2013/10
|
17.
|
◎石森紀子, 今井陽一, 榎本有希, 渡邉彩, 兒玉聖子, 志村華絵, 田中紀奈, 浅野千尋, 三橋健次郎, 石山みどり, 風間啓至, 吉永健太郎, 志関雅幸, 森直樹, 増田道彦, 寺村正尚, 泉二登志子:
低悪性度B細胞性リンパ腫に対するベンダムスチン療法におけるサイトメガロウイルス再活性化の検討.
第75回日本血液学会学術集会,
札幌,
2013/10
|
18.
|
◎KODAIRA Hitomi, KOBAYASHI Sumiko, 志村華絵, TAKAHASHI Hiromichi, NAKAGAWA Masaru, KUSUDA Machiko, KATO Michiko, TAKAYANAGI Takane, OCHIAI Toyoko, 今井陽一, 泉二登志子, 田中淳司, AMANO Yusuke, FUCHINOUE Fumi, SUGITANI Masahiko, HORIKOSHI Akira:
t(6;8) (p21;q24) in blastic plasmacytoid dendritic cell neoplasma.
第75回日本血液学会学術集会,
札幌,
2013/10
|
19.
|
◎塩崎宏子, 吉永健太郎, 近藤年昭, 今井陽一, 志関雅幸, 森直樹, 寺村正尚, 泉二登志子:
Doner cell leukemia after cord blood transplantation: Compareing to BM as transplanted source.
第75回日本血液学会学術集会,
札幌,
2013/10
|
20.
|
◎吉永健太郎, 森直樹, 石森紀子, テインイエ, 安並毅, 風間啓至, 志関雅幸, 泉二登志子, 田中淳司:
Coexistance of lupus anticoagulant, factor VIII and IX inhibitor in a patient with scleroderma.
第75回日本血液学会学術集会,
札幌,
2013/10
|
21.
|
◎志関雅幸, 森直樹, 石井真由子, 王鷲真理, 王艶華, 吉永健太郎, 岡田美智子, 泉二登志子, 田中淳司:
Analysis of expression of genes in common deleted region of del(20q) in MDS cases.
第75回日本血液学会学術集会,
札幌,
2013/10
|
22.
|
◎田中紀奈, 今井陽一, 風間啓至, 寺村正尚, 栗原佐知子, 榎本有希, 兒玉聖子, 吉永健太郎, 志関雅幸, 森直樹, 泉二登志子:
A case of acute myeloid leukemia with t(11;19) (q23;p13.1) accompanied by severe DIC.
第75回日本血液学会学術集会,
札幌,
2013/10
|
23.
|
◎風間啓至, 寺村 正尚, 栗原佐知子, 吉永健太郎, 加藤智啓, 泉二登志子:
Peroxiredoxin 2 expression is elevated in the neutrophils of patients with myelodysplastic syndromes.
第75回日本血液学会学術集会,
札幌,
2013/10
|
24.
|
◎志村華絵, 今井陽一, 吉永健太郎, 志関雅幸, 森直樹, 田中淳司, 菅野仁:
G6PD異常症を合併した鎌状赤血球症の1例.
第170回日本血液学会例会,
東京,
2013/07
|
25.
|
◎三橋健次郎, 志関雅幸, 吉永健太郎, 今井陽一, 森直樹, 寺村正尚, 泉二登志子:
リツキシマブ併用化学療法を受けたびまん性大細胞型B細胞リンパ腫における改訂国際予後指標の有用性.
第110回日本内科学会総会・講演会,
東京,
2013/04
|
Display 5 items
|
Display all(25)
|
To the top
|
|